Volume II. Vigilance of clinical trials Conduct of research involving the human person mentioned in 1 ° of Article L. 1121-1 of the public health code relating to the drug: Adverse reaction reporting, developments and reports annual security JANUARY 2020 admin 12 February 2020 All news
